Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

NCT03325595 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: AEF0117
DRUG: Placebo

Sponsor

Aelis Farma

Collaborators

[object Object]